Kromogeksal
Active material: Cromoglicic acid
When ATH: R01AC01
CCF: Stabilizers fat cell membranes. Allergy medication
ICD-10 codes (testimony): J30.1, J30.3
When CSF: 13.02.03.01
Manufacturer: Hexal AG (Germany)
Pharmaceutical form, composition and packaging
| ◊ Spray nazalynыy 2% | 1 dose (0.14 ml) |
| cromoglicic acid (in the form of the disodium salt) | 2.8 mg |
Excipients: benzalkonium chloride, EDTA, sodium chloride, sodium dihydrogen, sodium monohydrogenphosphate, sorbitol, water d / and.
15 ml – Plastic bottles with a dosing device (1) – packs cardboard.
30 ml – Plastic bottles with a dosing device (1) – packs cardboard.
Pharmacological action
Stabilizers fat cell membranes. Allergy medication. Blocks the entrance of ions in mast cells, preventing its degranulation and the release of mediators of allergy and inflammation (histamine, ʙradikinin, prostaglandins, leukotrienes and other biologically active substances). Prevents display of immediate type allergic reactions.
Pharmacokinetics
The data on the pharmacokinetics kromogeksal not provided.
Testimony
- Prevention and treatment of seasonal and / or year-round rhinitis allergic genesis.
Dosage regimen
Adults and children It recommended to appoint 1 dose (2.8 mg) in each nostril 4 times / day.
If necessary, the daily dose may be increased to a maximum of 6 time (16.8 mg)/d.
After achieving a therapeutic effect kromogeksal frequency of application can be reduced and the use of the drug while, while there is contact with the allergenic factors (house dust, fungal spores, pollen).
For the injection, remove the protective cap, enter the atomizing device into a nostril and strongly push the spray mechanism. The first use of the vial should be pressed several times to spray mechanism before the liquid droplets.
Side effect
Maybe: rarely – slight irritation in the nose; rarely – headache, a temporary violation of taste perception; in a few cases – nosebleeds, irritation of the mucous membranes of the nose, swelling of the tongue, larynx, hoarseness, severe generalized anaphylactic reactions with bronchospasm, coughing and choking.
If there are significant side effects, and complaints, not specified above, the patient should consult a doctor.
Contraindications
- Hypersensitivity to kromoglitsievoy acid or other components of the drug.
Pregnancy and lactation
Despite the lack of data about the negative impact of the drug on the fetus during pregnancy, especially in the I trimester, Kromogeksal should be taken with caution.
Cromoglicic acid in small quantities in breast milk passes, therefore taking the drug while breast-feeding is possible only in case, if the expected benefit to the mother outweighs the potential risk to the child.
Cautions
–
Overdose
Data on drug overdose kromogeksal not provided.
Drug Interactions
When using sodium cromoglycate with oral and inhaled forms of beta-agonists, oral corticosteroids and inhaled forms, theophylline and other methylxanthine derivatives, antihistamines, possible effect potentiation.
Preparations Bromhexine and Ambroxol should not be inhaled simultaneously with a solution kromogeksal.
Conditions of supply of pharmacies
The drug is resolved to application as an agent Valium holidays.
Conditions and terms
The drug should be stored in the dark, inaccessible to children at temperature not exceeding 25 ° C. Shelf life – 3 year.
Opened vials should be used within 6 weeks.
